Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin

Pancreas

Volumn 19, Issue 4, 1999, Pages 325-334

  Bläckberg, Mats ^a   Berling, Rikard ^b   Ohlsson, Kjell ^b  

^a HELSINGBORG HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aprotinin; Enzyme immunoassay; Kallistatin; Pancreatitis; Radioimmunoassay; Tissue kallikrein

Indexed keywords

APROTININ; TISSUE KALLIKREIN;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; KALLIKREIN KININ SYSTEM; MALE; PATHOPHYSIOLOGY; PERITONEAL FLUID; PERITONEUM EXUDATE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0344994505     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199911000-00002     Document Type: Article

References (40)

1. Mindroiu T, Carretero OA, Proud D, Walz D, Scicli AG. A new kinin moiety in human plasma kininogens. Biochem Biophys Res Commun 1988;152:519-26.
2. Dietl T, Kruck J, Fritz H. Localization of kallikrein in porcine pancreas and submandibular gland as revealed by the indirect immunofluorescence technique. Hoppe Seylers Z Physiol Chem 1978; 359:499-505.
3. Orstavik TB. Cellular origin of pancreatic kallikrein: a review. Adv Exp Med Biol 1983;156:347-56.
4. Amouric M, Figarella C. Characterization and purification of a kallikrein from human pancreatic juice and immunological comparison with other kallikreins. Hoppe Seylers Z Physiol Chem 1979;360:457-65.
5. Ofstad E. Formation and destruction of plasma kinins during experimental acute hemorrhagic pancreatitis in dogs. Scand J Gastroenterol 1970;5(suppl 5):7-44.
6. Rocha E, Silva M, Beraldo WT, Rosenfeld G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulins by snake venoms and by trypsin. Am J Physiol 1949;156:261-73.
7. Seidel G. Two functionally different kininogens in human plasma. Agents Actions 1973;3:12-9.
8. Bläckberg M, Ohlsson K. Studies on the release of tissue kallikrein in experimental pancreatitis in the pig. Eur Surg Res 1994;26:116-24.
9. Hjelmqvist B, Borgström A, Ohlsson K. Interactions in vitro and in vivo between anionic and cationic porcine trypsin and porcine plasma proteinase inhibitors. Biol Chem Hoppe Seyler 1988;369: 1331-6.
10. Chao J, Chao L. Biochemistry, regulation and potential function of kallistatin. Biol Chem Hoppe Seyler 1995;376:705-13.
11. 1-proteinase inhibitor). Hoppe Seylers Z Physiol Chem 1981;362:317-25.
12. Chao J, Chen KX, Chao L. Expression of kallikrein-binding protein and alpha 1-antitrypsin genes in response to sex hormones, growth, inflammation and hypertension. Agents Actions 1992;Suppl 38:174-81.
13. Chao J, Schmaier A, Chen LM, Yang Z, Chao L. Kallistatin, a novel tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease. J Lab Clin Med 1996;127:612-20.
14. Berling R, Genell S, Ohlsson K. High-dose intraperitoneal aprotinin treatment of acute severe pancreatitis: a double-blind randomized multi-center trial. J Gastroenterol 1994;29:479-85.
15. Imrie CW, Benjamin IS, Ferguson JC, et al. A single-centre double-blind trial of trasylol therapy in primary acute pancreatitis. Br J Surg 1978;65:337-41.
16. Burnette WN. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radio-iodinated protein A. Anal Biochem 1981;112:195-203.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
18. Amundsen E, Putter J, Friberger P, Knos M, Larsbraten M, Claeson G. Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv Exp Med Biol 1979;120A:83-95.
19. Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29(suppl 124):21-37.
20. Mancini G, Carbonara AO, Hereman JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965;2:235-53.
21. Markwell MA. A new solid-state agent to iodinate proteins. Anal Biochem 1982;125:427-32.
22. Rawlins TGR. Yrjönen T. Calculation of RIA results using the spline function, Int Lab 1978;55-66.
23. Mann K, Göring W, Lipp W, Keipert B, Karl HJ. Radioimmunoassay of human urinary kallikrein. J Clin Chem Clin Biochem 1980;18:395-401.
24. 1-antitrypsin-tissue kallikrein complexes in synovial fluid of patients with rheumatoid, osteo and psoriatic arthritis. Agents Actions 1992;(suppl 38):389-96.
25. Franke M, Rorchneider S, Geiger R. Enzyme Immunoassay of human urinary kallikrein. J Clin Chem Clin Biochem 1982;20: 621-6.
26. Shimamoto K, Mayfield RK, Margolius HS, Chao J, Stroud W, Kaplan AP. Immunoreactive tissue kallikrein in human serum. J Lab Clin Med 1984;103:731-8.
27. Bagshaw AF, Bhoola KD, Lemon MJC, Whicher JT. Development and characterization of a radioimmunoassay to measure human tissue kallikrein in biological fluids. J Endocrinol 1984;101:173-9.
28. Nishimura K, Inoue Y, Kokubu T. Radioimmunoassay of glandular kallikrein in human plasma after partial purification by immunoaffinity column. Clin Chim Acta 1987;162:341-7.
29. 2-macroglobulin. Biochem J 1976;157:521-4.
30. 2-macroglobulin do not inhibit the kinin-releasing activity of kallikreins from human urine and saliva. Biochim Biophys Acta 1980;633:305-9.
31. Kortmann H, Fink E, Bönner G. The influence of the kallikreinkinin system in the development of the pancreatic shock. Adv Exp Med Biol 1984;167:495-503.
32. Uehara S, Honjyo KS, Furokawa S, Hirayama A, Sakamoto W. Role of the kallikrein-kinin system in human pancreatitis. Adv Exp Med Biol 1989;247B:643-8.
33. Ecke S, Geiger R, Resch I, et al. Inhibition of tissue kallikrein by protein C inhibitor. J Biol Chem 1992;267:7048-52.
34. Bläckberg M, Ohlsson K. Interactions in vitro and in vivo between porcine tissue kallikrein and porcine plasma proteinase inhibitors. Scand J Clin Lab Invest 1994;54:643-51.
35. Sumi H, Takasugi T, Toki N. Studies on kallikrein-kinin system in plasma of patients with acute pancreatitis. Clin Chim Acta 1978; 87:113-8.
36. Takasugi S, Toki N, Sumi H. Studies on a kallikrein-kinin system in plasma of patients with acute pancreatitis: the preparation and characterization of a kallikrein-like enzyme in patients plasma. Clin Biochem 1980;13:156-9.
37. Bieth JG. In vivo significance of kinetic constants of macromolecular proteinase inhibitors. Adv Exp Med Biol 1984;167:97-109.
38. Chao J, Stallone JN, Liang Y-M, Chen L-M, Wang D-Z, Chao L. Kallistatin is a potent new vasodilator. J Clin Invest 1997;100: 11-7.
39. Hiltunen J, Kaukinen S, Pessi T, Ylitalo P. The kallikrein-kinin system in operated and non-operated patients with acute pancreatitis. Acta Chir Scand 1985;151:371-5.
40. Xiong W, Tang CQ, Zhou GX, Chao L, Chao J. In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein. J Lab Clin Med 1992;119:514-21.